You just read:

Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE

News provided by

Cernostics, Inc.

Mar 03, 2020, 07:00 ET